Wordt geladen...
Successful Alectinib Treatment for Carcinoma of Unknown Primary with EML4-ALK Fusion Gene: A Case Report
Gene alteration in anaplastic lymphoma kinase (ALK) is rare, and the efficacy of ALK inhibitors in the treatment of carcinoma of unknown primary (CUP) with ALK alteration remains unclear. The patient was a 56-year-old woman who presented with cervical lymph node swelling. Computed tomography reveale...
Bewaard in:
| Gepubliceerd in: | Curr Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8161847/ https://ncbi.nlm.nih.gov/pubmed/34064158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28030180 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|